XML 47 R41.htm IDEA: XBRL DOCUMENT v3.24.3
Restatement of Previously Issued Financial Statements - Schedule of Restatement of Previously Issued Financial Statements - Condensed Consolidated Statements Of Comprehensive Income (Loss) (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenue:        
Revenue $ 158,839 $ 159,169 $ 312,021 $ 324,549
Costs and operating expenses:        
Cost of goods sold 77,314 79,307 153,705 161,152
Research and development 10,575 9,706 21,813 21,860
Selling, general and administrative 65,481 49,084 127,284 105,372
Contingent consideration 0 1,791 0 3,026
Total costs and operating expenses 153,370 139,888 302,802 291,410
Income from operations 5,469 19,281 9,219 33,139
Other income (expenses):        
Investment income 9,411 5,964 18,404 11,450
Interest expense (5,118) (411) (10,147) (819)
Amortization of debt issuance costs (520) (457) (1,003) (914)
Other (expenses) income (215) 528 (3,751) 605
Other income, net 3,558 5,624 3,503 10,322
Income before income taxes 9,027 24,905 12,722 43,461
Income tax provision 3,314 5,119 3,713 8,338
Net income $ 5,713 $ 19,786 $ 9,009 $ 35,123
Earnings per share:        
Basic $ 0.1 $ 0.36 $ 0.16 $ 0.63
Diluted (Note 13) $ 0.1 $ 0.35 $ 0.16 $ 0.62
Weighted average common shares outstanding:        
Basic 55,884 55,705 55,838 55,648
Diluted (Note 13) 56,434 56,858 56,477 56,932
Net Income (Loss) $ 5,713 $ 19,786 $ 9,009 $ 35,123
Other comprehensive income (loss):        
Foreign currency translation adjustment (1,503) (6,079) (6,637) (3,092)
Comprehensive income (loss) 4,210 13,707 2,372 32,031
Product        
Revenue:        
Revenue 158,804 159,133 311,950 324,474
Royalty and other revenue        
Revenue:        
Revenue 35 $ 36 71 $ 75
As Previously Reported        
Revenue:        
Revenue 154,073   305,419  
Costs and operating expenses:        
Cost of goods sold 77,314   153,705  
Research and development 10,575   21,813  
Selling, general and administrative 64,697   126,383  
Contingent consideration 0   0  
Total costs and operating expenses 152,586   301,901  
Income from operations 1,487   3,518  
Other income (expenses):        
Investment income 9,411   18,404  
Interest expense (4,981)   (9,872)  
Amortization of debt issuance costs (520)   (1,003)  
Other (expenses) income (215)   (3,751)  
Other income, net 3,695   3,778  
Income before income taxes 5,182   7,296  
Income tax provision 1,861   1,881  
Net income $ 3,321   $ 5,415  
Earnings per share:        
Basic $ 0.06   $ 0.1  
Diluted (Note 13) $ 0.06   $ 0.1  
Weighted average common shares outstanding:        
Basic 55,884   55,838  
Diluted (Note 13) 56,434   56,477  
Net Income (Loss) $ 3,321   $ 5,415  
Other comprehensive income (loss):        
Foreign currency translation adjustment (1,531)   (6,812)  
Comprehensive income (loss) 1,790   (1,397)  
As Previously Reported | Product        
Revenue:        
Revenue 154,038   305,348  
As Previously Reported | Royalty and other revenue        
Revenue:        
Revenue 35   71  
Revenue Adjustments        
Revenue:        
Revenue 4,766   6,602  
Costs and operating expenses:        
Cost of goods sold 0   0  
Research and development 0   0  
Selling, general and administrative 0   0  
Contingent consideration 0   0  
Total costs and operating expenses 0   0  
Income from operations 4,766   6,602  
Other income (expenses):        
Investment income 0   0  
Interest expense 0   0  
Amortization of debt issuance costs 0   0  
Other (expenses) income 0   0  
Other income, net 0   0  
Income before income taxes 4,766   6,602  
Income tax provision 1,757   2,195  
Net income $ 3,009   $ 4,407  
Earnings per share:        
Basic $ 0.05   $ 0.08  
Diluted (Note 13) $ 0.05   $ 0.08  
Weighted average common shares outstanding:        
Basic 0   0  
Diluted (Note 13) 0   0  
Net Income (Loss) $ 3,009   $ 4,407  
Other comprehensive income (loss):        
Foreign currency translation adjustment 28   175  
Comprehensive income (loss) 3,037   4,582  
Revenue Adjustments | Product        
Revenue:        
Revenue 4,766   6,602  
Revenue Adjustments | Royalty and other revenue        
Revenue:        
Revenue 0   0  
Other Adjustments        
Revenue:        
Revenue 0   0  
Costs and operating expenses:        
Cost of goods sold 0   0  
Research and development 0   0  
Selling, general and administrative 784   901  
Contingent consideration 0   0  
Total costs and operating expenses 784   901  
Income from operations (784)   (901)  
Other income (expenses):        
Investment income 0   0  
Interest expense (137)   (275)  
Amortization of debt issuance costs 0   0  
Other (expenses) income 0   0  
Other income, net (137)   (275)  
Income before income taxes (921)   (1,176)  
Income tax provision (304)   (363)  
Net income $ (617)   $ (813)  
Earnings per share:        
Basic $ (0.01)   $ (0.02)  
Diluted (Note 13) $ (0.01)   $ (0.02)  
Weighted average common shares outstanding:        
Basic 0   0  
Diluted (Note 13) 0   0  
Net Income (Loss) $ (617)   $ (813)  
Other comprehensive income (loss):        
Foreign currency translation adjustment 0   0  
Comprehensive income (loss) (617)   (813)  
Other Adjustments | Product        
Revenue:        
Revenue 0   0  
Other Adjustments | Royalty and other revenue        
Revenue:        
Revenue $ 0   $ 0